• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Healthmedicine

CVS, Walmart and Walgreens-brand Mucinex may contain potent carcinogen benzene

By
Anna Edney
Anna Edney
and
Bloomberg
Bloomberg
Down Arrow Button Icon
By
Anna Edney
Anna Edney
and
Bloomberg
Bloomberg
Down Arrow Button Icon
August 12, 2024, 7:25 AM ET
Miami Beach, Fla., Walgreens, Pharmacy over the counter cold and flu medicine, NyQuil, DayQuil, Mucinex.
Miami Beach, Fla., Walgreens, Pharmacy over the counter cold and flu medicine, NyQuil, DayQuil, Mucinex. Jeffrey Greenberg—Universal Images Group/Getty Images

While it may seem like the only difference between extended-release Mucinex and its generic store-brand counterpart is the price tag, the latter potentially exposes users to a deadly cancer-causing chemical. 

Millions of Americans who buy the store-brand option at various major US chains are unknowingly choosing a drug that risks containing a potent carcinogen called benzene, according to a Bloomberg analysis of government data. Benzene can cause blood cancers such as leukemia and lymphoma. 

Just looking at the boxes, consumers wouldn’t easily be able to spot the difference between the two medicines. They both contain the same active ingredient, guaifenesin. And while the inactive ingredients differ, benzene isn’t listed among them. It instead lurks in an inactive ingredient, a white powder called a carbomer.

Both medicines use carbomers to create an extended-release phenomenon that helps relieve symptoms over a 12-hour period. But while the brand-name version, sold by the British drugmaker Reckitt Benckiser Group Plc, uses a carbomer that isn’t made with benzene, the generic ones sold as store brands by CVS, Walmart, Target and Walgreens use a cheaper one made with the harmful chemical, Bloomberg found.

US regulators have allowed drugmakers to use benzene for decades, even though international authorities have said they shouldn’t. In recent years, testing has found dangerously high levels of the chemical in some products in the US, raising concerns. Last year, the US Food and Drug Administration said the ingredient would be phased out of pharmaceutical use in 2025, a deadline that has been extended to 2026 following industry complaints.

“The FDA is continuously working to ensure that all drugs meet the highest quality standards with the health and well-being of Americans top of mind,” Amanda Hils, a spokesperson for the agency, said.

In response to Bloomberg’s questions about generic Mucinex having benzene, CVS Health Corp. said the company would work with its supplier to replace the ingredient. Walgreens Boots Alliance Inc. said it works with its suppliers to follow FDA regulations. Walmart Inc., Target Corp. and Rite Aid Corp. didn’t respond to requests for comment.

The FDA has also been studying drugs sold in gel form that use carbomers. Tablets, like generic Mucinex, are not included in that analysis, Hils said. She didn’t offer details on the results of the testing. 

Bloomberg’s analysis found a few dozen drugs besides generic Mucinex that still contain carbomers made using benzene including Walgreens’ version of Anbesol, an oral pain reliever; Walmart’s Equate brand face moisturizer with sunscreen; and Rite Aid’s version of Bengay muscle rub. 

While most shoppers trust that store-brand medicines are just as safe and effective as brand-name ones, that’s not always true. Generic drugs of all sorts, from eye drops to cancer treatments, have been linked to factories using unsafe practices, often to cut costs.

When it comes to store-brand generics, the retailer isn’t responsible for the quality of the products it sells. Instead, oversight and liability lies with the manufacturer. 

In the case of generic Mucinex, the major US chains all source their extended-release mucus-relief medicine from the same New Jersey company, Amneal Pharmaceuticals Inc. The drugmaker didn’t respond to requests for comment, including questions about whether it tested its drugs for potential benzene contamination or how it plans to comply with upcoming FDA regulations. 

Swapping ingredients is “dramatically costly and dramatically time consuming” because it requires additional testing and another round of FDA approval, said Vivek Dave, an associate professor of pharmaceutical sciences at St. John Fisher University in New York. 

Prices for carbomers are not made public and companies that sell them contacted by Bloomberg didn’t respond to inquiries. On Amazon, India-based Bangalore Fine Chemicals lists about four ounces of a carbomer made with benzene for $4 less than the one without. Drugmakers buying in bulk would potentially have to pay hundreds of thousands of dollars more for a less risky carbomer.

The inventor of Mucinex says there’s no scientific or therapeutic reason to use a carbomer made with benzene. “Clearly, benzene is not viewed fondly,” said Jeff Keyser, who’s now the chief executive officer of a pharmaceutical startup called Renibus Therapeutics in Texas. “There are other things out there they can use.” 

The Fortune 500 Innovation Forum will convene Fortune 500 executives, U.S. policy officials, top founders, and thought leaders to help define what’s next for the American economy, Nov. 16-17 in Detroit. Apply here.
About the Authors
By Anna Edney
See full bioRight Arrow Button Icon
By Bloomberg
See full bioRight Arrow Button Icon

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.


Latest in Health

Huel Shake Review (2026): Expert Approved
HealthDietary Supplements
Huel Shake Review (2026): Expert Approved
By Emily PharesApril 17, 2026
22 hours ago
The 5 Best Biotin Supplements of 2026: Tested and Approved
HealthDietary Supplements
The 5 Best Biotin Supplements of 2026: Tested and Approved
By Emily PharesApril 17, 2026
1 day ago
Ivan Espinosa, chief executive officer of Nissan Motor Co
Successwork-life balance
The CEO of $8.5 billion Japanese car giant Nissan plays the drums in a band and hits the tennis courts to destress from the top job
By Emma BurleighApril 16, 2026
2 days ago
wyle
CommentaryHealth
‘The Pitt’ reveals why healthcare desperately needs a new front door
By Jeremy MorganApril 16, 2026
2 days ago
walt
Healthcyber
As a small business owner, I never expected to pay $100,000 protecting my business from ransomware
By Walter RowenApril 16, 2026
2 days ago
health
CommentaryHealth Care Service
Two physicians on ending the waiting-room era: bring care home
By Benjamin Kornitzer and Bill FristApril 16, 2026
2 days ago

Most Popular

Pope Leo warned the world is in ‘big trouble’ if Elon Musk becomes the first trillionaire
Success
Pope Leo warned the world is in ‘big trouble’ if Elon Musk becomes the first trillionaire
By Preston ForeApril 17, 2026
1 day ago
'We should absolutely be concerned about non-college-educated men today': higher rents, living at home, falling out of the labor market
Economy
'We should absolutely be concerned about non-college-educated men today': higher rents, living at home, falling out of the labor market
By Catherina GioinoApril 18, 2026
10 hours ago
The power has swung back to employers—and workers are paying for it in benefits, flexibility, and leverage
Workplace Culture
The power has swung back to employers—and workers are paying for it in benefits, flexibility, and leverage
By Marco Quiroz-GutierrezApril 17, 2026
1 day ago
Older millennials are starting to act like boomers in the housing market—and pulling away from the pack
Real Estate
Older millennials are starting to act like boomers in the housing market—and pulling away from the pack
By Nick LichtenbergApril 17, 2026
1 day ago
Iran has reopened the Strait of Hormuz—but experts say it now holds a card that works ‘almost like a nuclear deterrent’
Energy
Iran has reopened the Strait of Hormuz—but experts say it now holds a card that works ‘almost like a nuclear deterrent’
By Eva RoytburgApril 17, 2026
1 day ago
Jeff Bezos pledged $10 billion for climate change. With the 2030 clock ticking, his wife, Lauren Sánchez Bezos, is leading the charge to spend it
Environment
Jeff Bezos pledged $10 billion for climate change. With the 2030 clock ticking, his wife, Lauren Sánchez Bezos, is leading the charge to spend it
By Sydney LakeApril 15, 2026
3 days ago